Photo of Alessia Baccarini

Alessia Baccarini

  • ASSISTANT PROFESSOR Genetics and Genomic Sciences
Print ProfilePrint Profile

Education

  • BSc, La Sapienza di Roma

  • PhD, La Sapienza di Roma

Biography

    Dr. Alessia Baccarini is an Assistant Professor in the Department of Genetics and Genomic Sciences.  She trained in molecular biology and biotechnology at the University of Rome and Harvard Medical School; where she focused on the role of YAP in DNA damage and cancer.  She joined Mount Sinai in 2008, and led studies that uncovered one of the first known factors to control microRNA turnover and decay.  She subsequently helped lead work on the first microRNA decoy and sensor vector libraries, and developed a new high-throughput approach, called Sensor-seq, which enables genome-wide measure of microRNA activity. She used the microRNA sensor library to determine the quantitative relationship between a microRNA’s concentration and its capacity for target suppression.  These studies led to the finding that microRNAs only function above a threshold concentration, and that there is widespread post-transcriptional regulation of microRNA activity.  She is now investigating the functions of non-coding RNAs in cancer biology.  

Awards

  • -
    Paola Campese Award for Leukemia Research
    Italian Scientists and Scholars Foundation (ISSNAF)

Publications

Nair-Gupta P, Baccarini A, Tung N, Seyffer F, Florey O, Huang Y, Banerjee M, Overholtzer M, Roche PA, Tampé R, Brown BD, Amsen D, Whiteheart SW, Blander JM. TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation. Cell 2014 Jul; 158(3).

Parikh A, Lee C, Joseph P, Marchini S, Baccarini A, Kolev V, Romualdi C, Fruscio R, Shah H, Wang F, Mullokandov G, Fishman D, D'Incalci M, Rahaman J, Kalir T, Redline RW, Brown BD, Narla G, DiFeo A. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nature communications 2014; 5.

Agudo J, Ruzo A, Tung N, Salmon H, Leboeuf M, Hashimoto D, Becker C, Garrett-Sinha LA, Baccarini A, Merad M, Brown BD. The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids. Nature immunology 2014 Jan; 15(1).

Mullokandov G *, Baccarini A *, Ruzo A *, Jayaprakash AD, Tung N, Israelow B, Evans MJ, Sachidanandam R, Brown BD. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nature methods 2012 Aug; 9(8).

Baccarini A, Chauhan H, Gardner TJ, Jayaprakash AD, Sachidanandam R, Brown BD. Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cells. Current biology : CB 2011 Mar; 21(5).

Baccarini A, Brown BD. Monitoring microRNA activity and validating microRNA targets by reporter-based approaches. Methods in molecular biology (Clifton, N.J.) 2010; 667.

Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, Zingale A, Baccarini A, Lazzari G, Galli C, Naldini L. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nature biotechnology 2007 Dec; 25(12).

Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, Lapi E, Mantovani F, Damalas A, Citro G, Sacchi A, Del Sal G, Levrero M, Blandino G. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Molecular cell 2005 May; 18(4).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Baccarini did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Hess CSM Building Floor 5th Room 302
1470 Madison Avenue
New York, NY 10029